# Why does the world continue to struggle with effectively addressing hepatitis E?

**Authors:** Henrique Borges da Silva Grisard, Gislaine Fongaro

PMC · DOI: 10.17179/excli2025-9166 · EXCLI Journal · 2026-01-08

## Full-text entities

- **Diseases:** chronic hepatitis (MESH:D006521), HEV infection (MESH:D016751), cirrhosis (MESH:D005355), hemorrhage (MESH:D006470), infection (MESH:D007239), preterm birth (MESH:D047928), eclampsia (MESH:D004461), acute liver failure (MESH:D017114), deaths (MESH:D003643), viral hepatitis (MESH:D014777), hepatocellular carcinoma (MESH:D006528), stillbirth (MESH:D050497)
- **Chemicals:** ribavirin (MESH:D012254)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676], Homo sapiens (human, species) [taxon 9606], Hepatitis E virus [taxon 12461]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12946441/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC12946441/full.md

---
Source: https://tomesphere.com/paper/PMC12946441